Novo Nordisk Shows It Is Ready To Extend Its Obesity Portfolio

Novel Oral Obesity Drug Shows Promise

scale
Novo Nordisk revealed new obesity drug data • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category